@aorchid

A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients.

, , , , , , , , and . Am J Transplant, 5 (6): 1462--1468 (June 2005)
DOI: 10.1111/j.1600-6143.2005.00866.x

Description

valgcv 900mg/d was equivalent to historical controls which had included IV gcv daily for 14 weeks in mismatches.

Links and resources

Tags